Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

King Buys Aventis’ Synercid, Tilade, Intal; Will Add 85 Reps To Sales Force

Executive Summary

A potential Synercid indication in methicillin-resistant Staphylococcus aureus is one milestone trigger in King's agreement to purchase rights to the antibiotic and two asthma drugs from Aventis

You may also be interested in...



King To Discuss $46.5 Mil. In Medicaid Underpayments With HHS, DoJ

King plans to discuss its Medicaid rebate reporting with HHS and DoJ after acknowledging an estimated $46.5 mil. in underpayments between 1998 and 2002

King To Discuss $46.5 Mil. In Medicaid Underpayments With HHS, DoJ

King plans to discuss its Medicaid rebate reporting with HHS and DoJ after acknowledging an estimated $46.5 mil. in underpayments between 1998 and 2002

King Acknowledges Medicaid Accounting Errors; Wants Out Of Elan Deal

King has discovered errors in its Medicaid rebate accounting, the firm disclosed March 31

Related Content

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel